2017-03-0803:00
By Lee I-chia / Staff reporterThe Food and Drug Administration (FDA) yesterday said that another batch of AstraZeneca’s lipid-lowering drug Crestor was found to have been adulterated with counterfeit drugs, so the company has agreed to initiate a recall for all batches on the market.The administration last weekend confirmed that batch number MV503 of Crestor 10mg film-coated tablets contained counterfeit drugs in similar packaging, and all the medication from that batch was recalled from hospitals and pharmacies.“The agency received the report about the counterfeit drugs on Thursday last week and immediately launched an investigation; examinations confirmed that there were counterfeit drugs being sold,” administration Director-General Shou-Mei Wu (吳秀梅) said yesterday.The New Taipei District Prosecutors’ Office took two suspects into custody over the weekend, and they may face up to 10 years in prison or a fine up to NT$100 million (US$3.24 million) for producing counterfeit drugs under the Pharmaceutical Affairs Act (藥事法).Another consignment of Crestor 10mg film-coated tablets, batch number MK479, was also found to contain counterfeit drugs, so the FDA said it asked AstraZeneca to recall all batches of the product in the interests of public safety.“The main ingredient that has been added to the counterfeit drugs is actually another type of lipid-lowering drug, atorvastatin, that used to be commonly prescribed, so people who have taken the counterfeit drugs need not worry too much,” Wu said, adding that people should consult doctors or pharmacists if they have any questions.According to National Health Insurance (NHI) Administration statistics, more than 200,000 boxes of Crestor are prescribed each month in Taiwan by NHI physicians, administration official Chih Lan-hui (遲蘭慧) said.AstraZeneca told the administration that it has a sufficient quantity of the medication in stock t
9017DB93A9375880
By Lee I-chia / Staff reporterThe Food and Drug Administration (FDA) yesterday said that another batch of AstraZeneca’s lipid-lowering drug Crestor was found to have been adulterated with counterfeit drugs, so the company has agreed to initiate a recall for all batches on the market.The administration last weekend confirmed that batch number MV503 of Crestor 10mg film-coated tablets contained counterfeit drugs in similar packaging, and all the medication from that batch was recalled from hospitals and pharmacies.“The agency received the report about the counterfeit drugs on Thursday last week and immediately launched an investigation; examinations confirmed that there were counterfeit drugs being sold,” administration Director-General Shou-Mei Wu (吳秀梅) said yesterday.The New Taipei District Prosecutors’ Office took two suspects into custody over the weekend, and they may face up to 10 years in prison or a fine up to NT$100 million (US$3.24 million) for producing counterfeit drugs under the Pharmaceutical Affairs Act (藥事法).Another consignment of Crestor 10mg film-coated tablets, batch number MK479, was also found to contain counterfeit drugs, so the FDA said it asked AstraZeneca to recall all batches of the product in the interests of public safety.“The main ingredient that has been added to the counterfeit drugs is actually another type of lipid-lowering drug, atorvastatin, that used to be commonly prescribed, so people who have taken the counterfeit drugs need not worry too much,” Wu said, adding that people should consult doctors or pharmacists if they have any questions.According to National Health Insurance (NHI) Administration statistics, more than 200,000 boxes of Crestor are prescribed each month in Taiwan by NHI physicians, administration official Chih Lan-hui (遲蘭慧) said.AstraZeneca told the administration that it has a sufficient quantity of the medication in stock t
-
#KEY_LIST_START#
- 大發網 #KEY_LIST_END#
- 拉斯維加斯娛樂城 ETtoday 東森旅遊雲 拉斯維加斯娛樂城
- 大發網 資安高風險國家 台灣上榜 大發網
- 老子有錢 港務分公司總經理拜會市所 魏嘉賢分享花蓮史蹟老照片 老子有錢
- 拉斯維加斯娛樂城 蔡丁貴鬧場 林右昌不爽 拉斯維加斯娛樂城
- 拉斯維加斯娛樂城 丹麥少年寫歷史課作業 意外挖到二戰戰機 拉斯維加斯娛樂城
9017DB93A9375880
文章標籤
全站熱搜